Neoadjuvant Peptide Receptor Radionuclide Therapy in a Rare Case of Pediatric Primary Hepatic Gastrinoma.
Clin Nucl Med
; 49(4): e161-e163, 2024 Apr 01.
Article
en En
| MEDLINE
| ID: mdl-38427960
ABSTRACT
ABSTRACT Gastrinomas with predilection for the adult male population are located in the gastrinoma triangle (>90%). Primary hepatic gastrinoma especially in pediatric population is very rare. Peptide receptor radionuclide therapy has shown benefit in metastatic gastroenteropancreatic neuroendocrine tumors (NETs) with an increasing interest in expanding its role as neoadjuvant treatment modality to improve the surgical candidature in inoperable NETs. There is currently no literature supporting its role in the pediatric NET patients. We present a rare case of a young boy with primary hepatic gastrinoma where 177Lu-based peptide receptor radionuclide therapy in the neoadjuvant setting contributed to his final disease-free status.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Pancreáticas
/
Gastrinoma
/
Neoplasias Primarias Secundarias
/
Tumores Neuroendocrinos
Límite:
Adult
/
Child
/
Humans
/
Male
Idioma:
En
Revista:
Clin Nucl Med
Año:
2024
Tipo del documento:
Article